Cargando…

Antithrombin III and D-dimer levels as indicators of disease severity in patients with hyperlipidaemic or biliary acute pancreatitis

OBJECTIVE: To assess changes in anticoagulation and fibrinolytic systems between biliary and hyperlipidaemic acute pancreatitis (AP). METHODS: Patients with biliary or hyperlipidaemic AP were enrolled. Demographic and clinical data were collected, and antithrombin III (ATIII), protein C, protein S,...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Ning, Hao, Jianyu, Zhang, Donglei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536593/
https://www.ncbi.nlm.nih.gov/pubmed/28222624
http://dx.doi.org/10.1177/0300060516677929
_version_ 1783254041023741952
author Yang, Ning
Hao, Jianyu
Zhang, Donglei
author_facet Yang, Ning
Hao, Jianyu
Zhang, Donglei
author_sort Yang, Ning
collection PubMed
description OBJECTIVE: To assess changes in anticoagulation and fibrinolytic systems between biliary and hyperlipidaemic acute pancreatitis (AP). METHODS: Patients with biliary or hyperlipidaemic AP were enrolled. Demographic and clinical data were collected, and antithrombin III (ATIII), protein C, protein S, and D-dimer levels were investigated. RESULTS: A total of 45 patients with biliary AP and 50 patients with hyperlipidaemic AP were included (68 with mild AP and 27 with moderately-severe AP). ATIII and protein C levels in the mild AP group were significantly higher, but prothrombin time and D-dimer were significantly lower, versus the moderately-severe AP group. ATIII and D-dimer were found to be risk factors for moderately-severe AP. ATIII could predict AP severity, particularly in patients with biliary AP. D-dimer was a sensitive and specific predictor for disease severity in patients with AP, particularly in patients with hyperlipidaemic AP. CONCLUSION: ATIII and protein C levels decreased as severity of AP increased, particularly in cases of biliary AP. D-dimer levels increased with severity of AP, particularly in hyperlipidaemic AP. ATIII and D-dimer may be useful biomarkers for assessing AP severity in patients with biliary and hyperlipidaemic AP, respectively.
format Online
Article
Text
id pubmed-5536593
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-55365932017-10-03 Antithrombin III and D-dimer levels as indicators of disease severity in patients with hyperlipidaemic or biliary acute pancreatitis Yang, Ning Hao, Jianyu Zhang, Donglei J Int Med Res Research Reports OBJECTIVE: To assess changes in anticoagulation and fibrinolytic systems between biliary and hyperlipidaemic acute pancreatitis (AP). METHODS: Patients with biliary or hyperlipidaemic AP were enrolled. Demographic and clinical data were collected, and antithrombin III (ATIII), protein C, protein S, and D-dimer levels were investigated. RESULTS: A total of 45 patients with biliary AP and 50 patients with hyperlipidaemic AP were included (68 with mild AP and 27 with moderately-severe AP). ATIII and protein C levels in the mild AP group were significantly higher, but prothrombin time and D-dimer were significantly lower, versus the moderately-severe AP group. ATIII and D-dimer were found to be risk factors for moderately-severe AP. ATIII could predict AP severity, particularly in patients with biliary AP. D-dimer was a sensitive and specific predictor for disease severity in patients with AP, particularly in patients with hyperlipidaemic AP. CONCLUSION: ATIII and protein C levels decreased as severity of AP increased, particularly in cases of biliary AP. D-dimer levels increased with severity of AP, particularly in hyperlipidaemic AP. ATIII and D-dimer may be useful biomarkers for assessing AP severity in patients with biliary and hyperlipidaemic AP, respectively. SAGE Publications 2017-01-12 2017-02 /pmc/articles/PMC5536593/ /pubmed/28222624 http://dx.doi.org/10.1177/0300060516677929 Text en © The Author(s) 2017 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page(https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Research Reports
Yang, Ning
Hao, Jianyu
Zhang, Donglei
Antithrombin III and D-dimer levels as indicators of disease severity in patients with hyperlipidaemic or biliary acute pancreatitis
title Antithrombin III and D-dimer levels as indicators of disease severity in patients with hyperlipidaemic or biliary acute pancreatitis
title_full Antithrombin III and D-dimer levels as indicators of disease severity in patients with hyperlipidaemic or biliary acute pancreatitis
title_fullStr Antithrombin III and D-dimer levels as indicators of disease severity in patients with hyperlipidaemic or biliary acute pancreatitis
title_full_unstemmed Antithrombin III and D-dimer levels as indicators of disease severity in patients with hyperlipidaemic or biliary acute pancreatitis
title_short Antithrombin III and D-dimer levels as indicators of disease severity in patients with hyperlipidaemic or biliary acute pancreatitis
title_sort antithrombin iii and d-dimer levels as indicators of disease severity in patients with hyperlipidaemic or biliary acute pancreatitis
topic Research Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536593/
https://www.ncbi.nlm.nih.gov/pubmed/28222624
http://dx.doi.org/10.1177/0300060516677929
work_keys_str_mv AT yangning antithrombiniiiandddimerlevelsasindicatorsofdiseaseseverityinpatientswithhyperlipidaemicorbiliaryacutepancreatitis
AT haojianyu antithrombiniiiandddimerlevelsasindicatorsofdiseaseseverityinpatientswithhyperlipidaemicorbiliaryacutepancreatitis
AT zhangdonglei antithrombiniiiandddimerlevelsasindicatorsofdiseaseseverityinpatientswithhyperlipidaemicorbiliaryacutepancreatitis